Company: ACBM
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001640334-25-001999
Chunk: 12

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 12
---
 Operations

Three and Nine Months Ended September 30, 2025 and 2024 

For the three months ended September 30, 2025, we had no revenue or cost of revenue.  Our operating expenses were $115,099, which are primarily related to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $2,710. As a result, we had a net loss of $117,809 or $(0.00) per share (basic and diluted).

 12Table of Contents

For the three months ended September 30, 2024, we had no revenue or cost of revenue.  Our operating expenses were $9,106 which are primarily relating to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $1,123. As a result, we had a net loss of $10,229 or $(0.00) per share (basic and diluted).

For the nine months ended September 30, 2025, we had no revenue or cost of revenue.  Our operating expenses were $137,647, which are primarily related to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $6,025. As a result, we had a net loss of $143,672 or $(0.00) per share (basic and diluted).

For the nine months ended September 30, 2024, we had no revenue or cost of revenue.  Our operating expenses were $28,490, which are primarily relating to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $3,134. As a result, we had a net loss of $31,624 or $(0.00) per share (basic and diluted).

Liquidity and Capital Resources

The following table summarizes our changes in working capital from December 31, 2024 to September 30, 2025:

  September 30,2025  December 31,2024  Change  % Change Current assets $4,323  $5,076  $(753)  (14.8)%Current liabilities $436,942  $326,946  $109,996   33.6%Working capital (deficiency)